David Turkaly
Stock Analyst at JMP Securities
(2.22)
# 2,678
Out of 4,876 analysts
141
Total ratings
40.31%
Success rate
-3.85%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $11.03 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $58.82 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $74.77 | +33.74% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $238.53 | +17.39% | 18 | May 16, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $35 → $25 | $12.21 | +104.75% | 15 | May 9, 2025 | |
| ENOV Enovis | Maintains: Market Outperform | $62 → $55 | $32.26 | +70.49% | 2 | May 9, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $140 → $125 | $91.74 | +36.25% | 14 | May 7, 2025 | |
| CRWD CrowdStrike Holdings | Maintains: Market Outperform | $400 → $500 | $505.22 | -1.03% | 1 | May 5, 2025 | |
| SYK Stryker | Reiterates: Market Perform | n/a | $390.40 | - | 3 | May 5, 2025 | |
| TFX Teleflex | Reiterates: Market Perform | n/a | $119.58 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $12 → $7 | $1.85 | +278.38% | 6 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $50 | $21.77 | +129.67% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $26 | $10.46 | +148.57% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $18.09 | +76.89% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $8.14 | +96.56% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $112 | $80.74 | +38.72% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $2.18 | - | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $3.40 | -11.76% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $4 | $3.86 | +3.63% | 4 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $9.32 | -46.35% | 1 | Oct 6, 2017 |
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $11.03
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $58.82
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $74.77
Upside: +33.74%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $238.53
Upside: +17.39%
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $12.21
Upside: +104.75%
Enovis
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $32.26
Upside: +70.49%
Zimmer Biomet Holdings
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $91.74
Upside: +36.25%
CrowdStrike Holdings
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $505.22
Upside: -1.03%
Stryker
May 5, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $390.40
Upside: -
Teleflex
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $119.58
Upside: -
Mar 21, 2025
Maintains: Market Outperform
Price Target: $12 → $7
Current: $1.85
Upside: +278.38%
Mar 21, 2025
Reiterates: Market Outperform
Price Target: $50
Current: $21.77
Upside: +129.67%
Mar 5, 2025
Reiterates: Market Outperform
Price Target: $26
Current: $10.46
Upside: +148.57%
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $18.09
Upside: +76.89%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $8.14
Upside: +96.56%
Jan 14, 2025
Reiterates: Market Outperform
Price Target: $112
Current: $80.74
Upside: +38.72%
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $2.18
Upside: -
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $3.40
Upside: -11.76%
Apr 13, 2023
Maintains: Outperform
Price Target: $7 → $4
Current: $3.86
Upside: +3.63%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $9.32
Upside: -46.35%